酰胺质子转移加权MRI与扩散加权成像在膀胱癌中的应用:VI-RADS的补充工具
前瞻性研究纳入106例病理确诊膀胱癌患者,评估APTw和扩散加权MRI定量参数在鉴别肌层浸润性膀胱癌(MIBC)与非肌层浸润性膀胱癌(NMIBC)中的价值。MIBC组ADC值更低、APTw值更高,APTw和ADC均可提升VI-RADS诊断效能,三者联合AUC达0.93。
要点
- MIBC组ADC值低于NMIBC组,APTw值高于NMIBC组,差异均有统计学意义。
- APTw和ADC值均可提升VI-RADS鉴别MIBC与NMIBC的诊断效能。
- VI-RADS联合ADC及APTw三者联合诊断肌层浸润的AUC最高,为0.93。
核心结论
- APTw和扩散加权MRI衍生参数可准确评估膀胱癌肌层浸润状态,并为VI-RADS提供附加价值。
研究设计与样本
- 前瞻性研究,2020年7月至2023年1月纳入106例病理确诊膀胱癌患者(平均年龄64±12岁,90例男性),术前接受包含APTw和扩散加权MRI的多参数MRI检查。
关键影像表现/征象
- MIBC组ADC值为0.88×10-3 mm2/s±0.12,NMIBC组为1.08×10-3 mm2/s±0.25,MIBC组更低(P<0.001)。
- MIBC组APTw值为6.89%(IQR 5.05%-12.17%),NMIBC组为3.61%(IQR 2.23%-6.83%),MIBC组更高(P<0.001)。
诊断标准与关键数值
- APTw联合VI-RADS较单独VI-RADS提升鉴别MIBC与NMIBC的诊断效能(P=0.003)。
- ADC联合VI-RADS较单独VI-RADS提升鉴别MIBC与NMIBC的诊断效能(P=0.020)。
- VI-RADS+ADC+APTw三者联合评估肌层浸润状态的AUC为0.93(95%CI 0.87-0.97)。
- 在VI-RADS+ADC基础上加入APTw值可显著提升鉴别NMIBC与MIBC的诊断效能(VI-RADS+ADC vs VI-RADS+APTw+ADC,P=0.046)。
临床应用与阅片要点
- VI-RADS评分可结合APTw和ADC定量参数,以提高鉴别MIBC与NMIBC的准确性。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
RATIONALE AND OBJECTIVES: To investigate the feasibility of amide proton transfer-weighted (APTw) and diffusion-weighted Magnetic Resonance Imaging (MRI) as a means by which to add value to the Vesical Imaging Reporting and Data System (VI-RADS) for discriminating muscle invasive bladder cancer (MIBC) from nonmuscle invasive bladder cancer (NMIBC).
MATERIALS AND METHODS: This prospective study enrolled participants with pathologically confirmed bladder cancer (BCa) who underwent preoperative multiparametric MRI, including APTw and diffusion-weighted MRI, from July 2020 to January 2023. The exclusion criteria were lesions smaller than 10 mm, missing smooth muscle layer in the operation specimen, neoadjuvant therapy before MRI, inadequate image quality, and malignancy other than urothelial neoplasm. Two radiologists independently assigned the VI-RADS score for each participant. Quantitative parameters derived from APTw and diffusion-weighted MRI were obtained by another two radiologists. Receiver operating characteristic (ROC) curve analysis with the area under the ROC curve (AUC) was performed to evaluate the diagnostic performances of quantitative parameters for discriminating BCa detrusor muscle invasion status.
RESULTS: A total of 106 participants were enrolled (mean age, 64 ± 12 years [SD]; 90 men): 32 with MIBC and 74 with NMIBC. Lower apparent diffusion coefficient (ADC) values (0.88 × 10-3 mm2/s ± 0.12 vs. 1.08 × 10-3 mm2/s ± 0.25; P < 0.001) and higher APTw values (6.89% [interquartile range {IQR}, 5.05%-12.17%] vs. 3.61% [IQR, 2.23%-6.83%]; P < 0.001) were observed in the MIBC group. Compared to VI-RADS alone, both APTw (P = 0.003) and ADC (P = 0.020) values could improve the diagnostic performance of VI-RADS in differentiating MIBC from NMIBC. The combination of the three yielded the highest diagnostic performance (AUC, 0.93; 95% CI:0.87,0.97) for evaluating muscle invasion status. The addition of the APTw values to the combination of VI-RADS and ADC values notably improved the diagnostic performance for differentiating NMIBC from MIBC (VI-RADS+ADC vs. VI-RADS+APTw+ADC, P = 0.046).
CONCLUSION: MRI parameters derived from APTw and diffusion-weighted MRI can be used to accurately assess muscle invasion status in BCa and provide additional value to VI-RADS.
引用
- Kong L, Wen Z, Cai Q, et al. Amide Proton Transfer-Weighted MRI and Diffusion-Weighted Imaging in Bladder Cancer: A Complementary Tool to the VI-RADS. Acad Radiol. 2023. PMID: 37821347. doi:10.1016/j.acra.2023.09.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。